Patients' Access to Treatments Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 22, 2017)
Patients' Access to Treatments Act of 2017
This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.
What just happenedJun 23, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 22, 2017
- Jun 23, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 22, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jun 22, 2017IntroReferralIntro-H
Introduced in House
- Jun 22, 2017IntroReferral1000
Introduced in House